FORMULATION AND EVALUATION OF ELASTIC LIPOSOMES OF DECITABINE PREPARED BY ROTARY EVAPORATION METHOD
Keywords:
Decitabine, Elastic liposomes, in vitro drug release, rotary evaporation method, Span 60, Span 80Abstract
Objective: Decitabine is a cytidine deoxynucleoside analog, which acts by inhibiting DNA methyltransferase, and is used for the treatment of acute myeloid leukemia. Decitabine has a short half-life (25 minutes), and is sensitive to harsh conditions. Elastic liposomes are an effective tool that can be used to overcome this disadvantage. Elastic liposomes also known as transfersomes are modified lipid carriers that enable drug to reach deeper skin layers and/or the systemic circulation. These vesicular formulations are several orders of magnitudes, more deformable than the standard liposomes and thus well suited for skin penetration. The objective of present study is to develop and evaluate the elastic liposomes of Decitabine so as to provide the sustained release and improve its bioavailability.
Methods: Elastic liposomes were prepared by rotary evaporation method using Span 80 and Span 60 as a surfactants. The prepared Elastic liposomes were evaluated for entrapment efficiency, vesicle size, in vitro drug release. The drug release profiles from different elastic liposomes-in-vehicle formulations were in agreement with the physicochemical properties of the formulations.
Results: Based on different parameters formulations of batch ELS1 was found to be the best formulations. Stability study was performed on the selected formulation ELS1.
Conclusion: Study concludes that Decitabine can also be formulated in the liposomal carrier which finds its best way for the topical administration.
Peer Review History:
Received 4 April 2019; Revised 7 May; Accepted 28 June; Available online 15 July 2019
Academic Editor: Ahmad Najib, Universitas Muslim Indonesia, Indonesia, ahmad.najib@umi.ac.id
Received file: Reviewer's Comments:
Average Peer review marks at initial stage: 4.5/10
Average Peer review marks at publication stage: 7.5/10
Reviewer(s) detail:
Prof Dr. Ahmed Kadry Ibrahim Ibrahim Hassan, Atos pharma-Seke, Egypt, kadry_ibrahim173@yahoo.com
Dr. Hatem Sameir Abbas, Al-Azhar University, Egypt, hsam8406@yahoo.com
Downloads
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.